Literature DB >> 32918787

In Reply.

Silvia Stacchiotti1, Giacomo Giulio Baldi2, Paolo Giovanni Casali1.   

Abstract

Mesh：

Year:  2020        PMID： 32918787      PMCID： PMC8186402          DOI： 10.1002/ONCO.13518

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  8 in total

1.  Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG).

Authors:  Michela Casanova; Bernadette Brennan; Rita Alaggio; Anna Kelsey; Daniel Orbach; Max M van Noesel; Nadege Corradini; Veronique Minard-Colin; Ilaria Zanetti; Gianni Bisogno; Soledad Gallego; Johannes H M Merks; Gian Luca De Salvo; Andrea Ferrari
Journal:  Eur J Cancer       Date:  2020-01-30       Impact factor: 9.162

2.  Regarding "The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors".

Authors:  Patrick Schöffski
Journal:  Oncologist       Date:  2020-09-18

3.  Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.

Authors:  Patrick Schöffski; Jozef Sufliarsky; Hans Gelderblom; Jean-Yves Blay; Sandra J Strauss; Silvia Stacchiotti; Piotr Rutkowski; Lars H Lindner; Michael G Leahy; Antoine Italiano; Nicolas Isambert; Maria Debiec-Rychter; Raf Sciot; Thomas Van Cann; Sandrine Marréaud; Axelle Nzokirantevye; Sandra Collette; Agnieszka Wozniak
Journal:  Lancet Respir Med       Date:  2018-04-15       Impact factor: 30.700

4.  The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.

Authors:  Giacomo Giulio Baldi; Mehdi Brahmi; Salvatore Lo Vullo; Elena Cojocaru; Olivier Mir; Michela Casanova; Bruno Vincenzi; Tommaso Martino De Pas; Giovanni Grignani; Maria Abbondanza Pantaleo; Jean Yves Blay; Robin Lewis Jones; Axel Le Cesne; Anna Maria Frezza; Alessandro Gronchi; Paola Collini; Angelo Paolo Dei Tos; Carlo Morosi; Luigi Mariani; Paolo Giovanni Casali; Silvia Stacchiotti
Journal:  Oncologist       Date:  2020-07-12

5.  Inflammatory myofibroblastic tumors in children.

Authors:  Brian G A Dalton; Priscilla G Thomas; Nicole E Sharp; Michelle A Manalang; James E Fisher; Christopher R Moir; Shawn D St Peter; Corey W Iqbal
Journal:  J Pediatr Surg       Date:  2015-11-27       Impact factor: 2.545

6.  Inflammatory myofibroblastic tumor of the conjunctiva: response to chemotherapy with low-dose methotrexate and vinorelbine.

Authors:  Francesca Favini; Antonio Giordano Resti; Paola Collini; Michela Casanova; Cristina Meazza; Giovanna Trecate; Andrea Ferrari
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

7.  Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies.

Authors:  Rita Alaggio; Giovanni Cecchetto; Gianni Bisogno; Claudio Gambini; Maria Luisa Calabrò; Alessandro Inserra; Renata Boldrini; Gian Luca De Salvo; Emanuele S G d'Amore; Patrizia Dall'igna
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

8.  Inflammatory myofibroblastic tumors-A retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe.

Authors:  Stefanie Kube; Christian Vokuhl; Tobias Dantonello; Monika Scheer; Erika Hallmen; Simone Feuchtgruber; Gabriele Escherich; Felix Niggli; Ingrid Kuehnle; Thekla von Kalle; Stefan Bielack; Thomas Klingebiel; Ewa Koscielniak
Journal:  Pediatr Blood Cancer       Date:  2018-02-26       Impact factor: 3.167
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.